 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
3/11/24 Merck Sharp & Dohme LLC 4 10% Owner² 1:7K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
Merck & Co., Inc.
3/11/24 Merck Sharp & Dohme LLC SC 13D/A 1:49K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
Merck & Co., Inc.³
1/17/24 Merck Sharp & Dohme LLC 3 10% Owner² 1:9K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
Merck & Co., Inc.
1/18/24‡ Merck Sharp & Dohme LLC SC 13D 1/17/24 6:195K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
Hawaii Merger Sub, Inc.³
Merck & Co., Inc.³
1/10/24 Merck Sharp & Dohme LLC DFAN14A 1:23K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
1/8/24 Merck Sharp & Dohme LLC DFAN14A 1:51K Harpoon Therapeutics, Inc. Donnelley … Solutions/FA
2/14/23 Citadel Advisors LLC SC 13G/A 1:134K Imago BioSciences, Inc. Toppan Merrill/FA
Citadel GP LLC³
Citadel Securities GP LLC³
Citadel Securities Group LP³
Citadel Securities LLC³
Kenneth Griffin³
2/1/23 Farallon Capital Partners, L.P. SC 13G/A 1:564K Imago BioSciences, Inc.
1/26/23 BlackRock Inc. SC 13G/A 1:13K Imago BioSciences, Inc. BlackRock Energy & R… Tr
1/23/23 Imago BioSciences, Inc. 15-12G 1/23/23 1:11K Donnelley … Solutions/FA
1/20/23 BlackRock Inc. SC 13G/A 1:13K Imago BioSciences, Inc. BlackRock Energy & R… Tr
1/13/23‡ Imago BioSciences, Inc. EFFECT 1/13/23 1:2K SEC #5
1/12/23 Clarus Lifesciences III, L.P. SC 13D/A 1:142K Imago BioSciences, Inc. Donnelley … Solutions/FA
Blackstone Clarus III L.L.C.³
Blackstone Group Management L.L.C.³
Blackstone Holdings I/II GP L.L.C.³
Blackstone Holdings II L.P.³
Blackstone Inc.³
Clarus Ventures III GP, L.P.³
Stephen A. Schwarzman³
1/11/23 Keating Laurie 4 Director² 1:7K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Kariuki Enoch 4 Director² 1:8K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Tapper Amy E. 4 Officer² 1:12K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Rienhoff Hugh Jr. 4 Dir.,Off.² 1:12K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Eichorn Laura G. 4 Officer² 1:12K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Henner Dennis 4 Director² 1:7K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
1/11/23 Arenberg Michael 4 Officer² 1:8K Imago BioSciences, Inc. Donnelley Fin’l S… 06/FA
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Types: | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 15-12G | Certification of a Termination of Registration of a Class of Securities — Form 15. | | DFAN14A | Definitive Additional Non-Management Proxy Soliciting Material — Schedule 14A. | | EFFECT | SEC Notice of Effectiveness. | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
